First Header Logo Second Header Logo

Connection

Mark Chappell to Disease Progression

This is a "connection" page, showing publications Mark Chappell has written about Disease Progression.
Connection Strength

0.082
  1. Chappell MC, Gallagher PE, Averill DB, Ferrario CM, Brosnihan KB. Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat. Hypertension. 2003 Oct; 42(4):781-6.
    View in: PubMed
    Score: 0.047
  2. Yogasundaram H, Chappell MC, Braam B, Oudit GY. Cardiorenal Syndrome and Heart Failure-Challenges and Opportunities. Can J Cardiol. 2019 09; 35(9):1208-1219.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.